These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6291544

  • 1. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some pentasubstituted quercetin analogs.
    Picq M, Prigent AF, Nemoz G, Pacheco H.
    Biochem Pharmacol; 1982 Sep 01; 31(17):2777-82. PubMed ID: 6291544
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the different cyclic nucleotide phosphodiesterase isoforms separated from rat brain by flavonoid compounds.
    Picq M, Dubois M, Prigent AF, Némoz G, Pacheco H.
    Biochem Int; 1989 Jan 01; 18(1):47-57. PubMed ID: 2541724
    [Abstract] [Full Text] [Related]

  • 3. Pentasubstituted quercetin analogues as selective inhibitors of particulate 3':5'-cyclic-AMP phosphodiesterase from rat brain.
    Picq M, Prigent AF, Némoz G, André AC, Pacheco H.
    J Med Chem; 1982 Oct 01; 25(10):1192-8. PubMed ID: 6292419
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivatives.
    Némoz G, Prigent AF, Picq M, Pacheco H.
    Biochem Pharmacol; 1982 Nov 01; 31(21):3353-8. PubMed ID: 6293510
    [No Abstract] [Full Text] [Related]

  • 5. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC, Shih CM, Lai YH, Chen JH, Huang HL.
    Biochem Pharmacol; 2004 Nov 15; 68(10):2087-94. PubMed ID: 15476679
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds.
    Ruckstuhl M, Landry Y.
    Biochem Pharmacol; 1981 Apr 01; 30(7):697-702. PubMed ID: 6264919
    [No Abstract] [Full Text] [Related]

  • 7. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
    Donnelly TE, Barron B.
    Biochim Biophys Acta; 1981 Jan 15; 657(1):168-78. PubMed ID: 6260197
    [Abstract] [Full Text] [Related]

  • 8. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
    Van Inwegen RG, Salaman P, St Georgiev V, Weinryb I.
    Biochem Pharmacol; 1979 Apr 15; 28(8):1307-12. PubMed ID: 87199
    [No Abstract] [Full Text] [Related]

  • 9. Flavonoids are selective cyclic GMP phosphodiesterase inhibitors.
    Ruckstuhl M, Beretz A, Anton R, Landry Y.
    Biochem Pharmacol; 1979 Apr 15; 28(4):535-8. PubMed ID: 218594
    [No Abstract] [Full Text] [Related]

  • 10. Selective inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase by cyclic nucleotides and their analogues and various drugs [proceedings].
    Butt NM, Saeed SA, Collier HO.
    Biochem Soc Trans; 1980 Jun 15; 8(3):380-1. PubMed ID: 6249674
    [No Abstract] [Full Text] [Related]

  • 11. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
    Ahluwalia GS, Rhoads AR.
    Biochem Pharmacol; 1982 Mar 01; 31(5):665-9. PubMed ID: 6177320
    [Abstract] [Full Text] [Related]

  • 12. 1-(4-Aminobenzyl)-and 1-(4-aminophenyl)isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors.
    Walker KA, Boots MR, Stubbins JF, Rogers ME, Davis CW.
    J Med Chem; 1983 Feb 01; 26(2):174-81. PubMed ID: 6298424
    [Abstract] [Full Text] [Related]

  • 13. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties.
    Minneman KP.
    J Neurochem; 1976 Nov 01; 27(5):1181-9. PubMed ID: 12170605
    [Abstract] [Full Text] [Related]

  • 14. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE, Lakey T, Houslay MD.
    Biochem Pharmacol; 1989 Nov 15; 38(22):4123-36. PubMed ID: 2480793
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
    Turner NC, Wood LJ, Burns FM, Gueremy T, Souness JE.
    Br J Pharmacol; 1993 Apr 15; 108(4):876-83. PubMed ID: 8387385
    [Abstract] [Full Text] [Related]

  • 17. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov 15; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5.
    Shin HJ, Kim HJ, Kwak JH, Chun HO, Kim JH, Park H, Kim DH, Lee YS.
    Bioorg Med Chem Lett; 2002 Sep 02; 12(17):2313-6. PubMed ID: 12161123
    [Abstract] [Full Text] [Related]

  • 20. A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
    Weishaar RE, Cain MH, Bristol JA.
    J Med Chem; 1985 May 02; 28(5):537-45. PubMed ID: 2985781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.